Search

Your search keyword '"Matsumoto, Shigemi"' showing total 4 results
Start Over Author "Matsumoto, Shigemi" Journal cancer medicine
4 results on '"Matsumoto, Shigemi"'

1. Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity‐modulated radiotherapy for resectable pancreatic cancer: A prospective, open‐label, phase II study

Author

Masui, Toshihiko, primary, Nagai, Kazuyuki, additional, Anazawa, Takayuki, additional, Kasai, Yosuke, additional, Yogo, Akitada, additional, Yoshimura, Michio, additional, Mizowaki, Takashi, additional, Uza, Norimitsu, additional, Fukuda, Akihisa, additional, Matsumoto, Shigemi, additional, Kanai, Masashi, additional, Isoda, Hiroyoshi, additional, Kawaguchi, Yoshiya, additional, Uemoto, Shinji, additional, and Hatano, Etsuro, additional

Published
2023
Full Text
View/download PDF

2. Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine‐induced toxicity in an Asian population

Author

Kanai, Masashi, primary, Kawaguchi, Takahisa, additional, Kotaka, Masahito, additional, Manaka, Dai, additional, Hasegawa, Junichi, additional, Takagane, Akinori, additional, Munemoto, Yoshinori, additional, Kato, Takeshi, additional, Eto, Tetsuya, additional, Touyama, Tetsuo, additional, Matsui, Takanori, additional, Shinozaki, Katsunori, additional, Matsumoto, Shigemi, additional, Mizushima, Tsunekazu, additional, Mori, Masaki, additional, Sakamoto, Junichi, additional, Ohtsu, Atsushi, additional, Yoshino, Takayuki, additional, Saji, Shigetoyo, additional, and Matsuda, Fumihiko, additional

Published
2022
Full Text
View/download PDF

3. Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine‐induced toxicity in an Asian population.

Author

Kanai, Masashi, Kawaguchi, Takahisa, Kotaka, Masahito, Manaka, Dai, Hasegawa, Junichi, Takagane, Akinori, Munemoto, Yoshinori, Kato, Takeshi, Eto, Tetsuya, Touyama, Tetsuo, Matsui, Takanori, Shinozaki, Katsunori, Matsumoto, Shigemi, Mizushima, Tsunekazu, Mori, Masaki, Sakamoto, Junichi, Ohtsu, Atsushi, Yoshino, Takayuki, Saji, Shigetoyo, and Matsuda, Fumihiko

Subjects
DIHYDROPYRIMIDINE dehydrogenase, ASIANS, GENOME-wide association studies, GENOTYPES, COLON cancer
Abstract

Objective: Dihydropyrimidine dehydrogenase (DPYD) genotype is closely associated with fluoropyrimidine (FP)‐induced toxicities in Caucasian population and European Medicines Agency now recommends DPYD genotype‐based FP dosing strategy. Patients and Methods: The current study aimed to investigate their impact on FP‐related toxicities in an Asian population using genome‐wide association study (GWAS) data set from 1364 patients with colon cancer. Results: Among 82 variants registered in the Clinical Pharmacogenetics Implementation Consortium, 74 DPYD variants were directly genotyped in GWAS cohort; however, only 7 nonsynonymous DPYD variants (CPIC variants) were identified and none of the four recurrent DPYD variants (DPYD*2A, c.2846A>T, c.1679T>G, c.1236G>A) were included. Seven CPIC variants were investigated for their association with the incidence of FP‐related toxicities; however, none of these variants revealed a significant correlation with FP‐related toxicities. Conclusion: These data suggested that the DPYD genotype registered in CPIC plays a minor role in FP‐related toxicities in an Asian population. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results